Neurocognitive Disorders and Mental Illness

HIV HCV Curriculum Logo

This lesson focuses on neurocognitive disorders and mental illness among HCV co-infected People with HIV .

Download Slides

References

  1. Fialho R, Pereira M, Harrison N, Rusted J, Whale R. Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C. Psychiatry Research [serial online]. July 1, 2017;253:150-157. Available from: ScienceDirect, Ipswich, MA. Accessed May 11, 2017.
  2. Chiu W, Tsan Y, Tsai S, Chang C, Wang J, Chen P. Hepatitis C viral infection and the risk of dementia. European Journal Of Neurology [serial online]. n.d.;21(8):1068-+. Available from: Science Citation Index, Ipswich, MA. Accessed May 11, 2017.
  3. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789-1799. doi:10.1212/01.WNL.0000287431.88658.8b.
  4. Heaton R, Clifford D, Grant I, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study. Neurology [serial online]. n.d.;75(23):2087-2096. Available from: Science Citation Index, Ipswich, MA. Accessed May 11, 2017.
  5. Valcour V. HIV Neurology Persistence of Cognitive Impairment Despite cART. Lecture presented at: CROI; 2013; Atlanta, GA.
  6. Sevigny J, Albert S, Epstein L, et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Archives Of Neurology [serial online]. n.d.;64(1):97-102. Available from: Science Citation Index, Ipswich, MA. Accessed May 11, 2017.
  7. Vivithanaporn P, Heo G, Power C, et al. Neurologic disease burden in treated HIV/AIDS predicts survival A population-based study. Neurology [serial online]. n.d.;75(13):1150-1158. Available from: Science Citation Index, Ipswich, MA. Accessed May 11, 2017.
  8. Heaton R, Marcotte T, Grant I, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal Of The International Neuropsychological Society [serial online]. n.d.;10(3):317-331. Available from: Science Citation Index, Ipswich, MA. Accessed May 11, 2017.
  9. Heaton R, Velin R, Grant I, et al. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosomatic Medicine [serial online]. January 1994;56(1):8-17. Available from: MEDLINE, Ipswich, MA. Accessed May 11, 2017.
  10. Woods S, Moore D, Weber E, Grant I. Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders. Neuropsychology Review [serial online]. n.d.;19(2):152-168. Available from: Science Citation Index, Ipswich, MA. Accessed May 11, 2017.
  11. Hinkin C, Castellon S, Stefaniak M, et al. Medication adherence among HIV+ adults - Effects of cognitive dysfunction and regimen complexity. Neurology [serial online]. n.d.;59(12):1944-1950. Available from: Science Citation Index, Ipswich, MA. Accessed May 11, 2017.
  12. Marcotte T, Lazzaretto D, Scott J, Roberts E, Woods S, Letendre S. Visual Attention Deficits are Associated with Driving Accidents in Cognitively-Impaired HIV-Infected Individuals. Journal Of Clinical & Experimental Neuropsychology [serial online]. January 2006;28(1):13-28. Available from: Academic Search Premier, Ipswich, MA. Accessed May 11, 2017.
  13. Li P. HIV-Associated Neurocognitive Disorder (HAND). Lecture presented at: 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 2013.
  14. Fialho R, Rusted J, Bucur M, Whale R, Pereira M, Fisher M. Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis. AIDS Care - Psychological And Socio-Medical Aspects Of AIDS/HIV [serial online]. November 7, 2015;:14p.. Available from: Scopus®, Ipswich, MA. Accessed May 11, 2017.
  15. Clifford D, Vaida F, Heaton R, et al. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology [serial online]. January 20, 2015;84(3):241-250. Available from: CINAHL with Full Text, Ipswich, MA. Accessed May 11, 2017.
  16. Brooner R, King V, Kidorf M, Schmidt C, Bigelow G. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives Of General Psychiatry [serial online]. January 1997;54(1):71-80. Available from: MEDLINE, Ipswich, MA. Accessed May 11, 2017.
  17. Sherr L, Clucas C, Harding R, Sibley E, Catalan J. HIV and Depression - a systematic review of interventions. Psychology, Health & Medicine [serial online]. October 2011;16(5):493-527. Available from: Nursing & Allied Health Collection: Comprehensive, Ipswich, MA. Accessed May 11, 2017.
  18. Ickovics J, Hamburger M, Moore J, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. Jama [serial online]. March 21, 2001;285(11):1466-1474. Available from: MEDLINE, Ipswich, MA. Accessed May 11, 2017.
  19. Cook J, Grey D, Hessol N, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. American Journal Of Public Health [serial online]. July 2004;94(7):1133-1140. Available from: CINAHL with Full Text, Ipswich, MA. Accessed May 11, 2017.
  20. Antelman G, Kaaya S, Fawzi M, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women, in Tanzania. Jaids-Journal Of Acquired Immune Deficiency Syndromes [serial online]. n.d.;44(4):470-477. Available from: Science Citation Index, Ipswich, MA. Accessed May 11, 2017.
  21. Kroenke K, Spitzer R, Janet B. W. W. The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener. Medical Care [serial online]. 2003:1284. Available from: JSTOR Journals, Ipswich, MA. Accessed May 11, 2017.
  22. Bush K, Kivlahan D, McDonell M, Fihn S, Bradley K. The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Archives Of Internal Medicine [serial online]. September 14, 1998;158(16):1789-1795. Available from: Scopus®, Ipswich, MA. Accessed May 12, 2017.
  23. Yudko E, Lozhkina O, Fouts A. Regular article: A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. Journal Of Substance Abuse Treatment [serial online]. January 1, 2007;32:189-198. Available from: ScienceDirect, Ipswich, MA. Accessed May 12, 2017.
  24. Islam N, Krajden M, Janjua N, et al. Articles: Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study. The Lancet Gastroenterology & Hepatology [serial online]. March 1, 2017;2:200-210. Available from: ScienceDirect, Ipswich, MA. Accessed May 12, 2017.
  25. Helleberg M, Gerstoft J, Obel N, et al. Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS [serial online]. 2014 .;28(10):1499-1508. Available from: Science Citation Index, Ipswich, MA. Accessed May 12, 2017.
  26. Lawrence D, Mitrou F, Zubrick S. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health [serial online]. January 2009;9(1):285-298. Available from: Academic Search Premier, Ipswich, MA. Accessed May 12, 2017.
  27. Martin, Lindi, and Ashraf Kagee. Lifetime and HIV-related PTSD among persons recently diagnosed with HIV. AIDS and Behavior 15.1 (2011): 125-131.
  28. Smith, Meredith Y., et al. The impact of PTSD on pain experience in persons with HIV/AIDS. Pain. 98.1 (2002): 9-17.

Resources

Mental Health and Depression

Substance Use Disorders